Abstract:Despite considerable research efforts, it is still not clear which mechanisms underlie neuronal cell death in neurodegenerative diseases. During the last 20 years, multiple pathways have been identified that can execute regulated cell death (RCD). Among these RCD pathways, apoptosis, necroptosis, pyroptosis, ferroptosis, autophagy-related cell death, and lysosome-dependent cell death have been intensively investigated. Although RCD consists of numerous individual pathways, multiple common proteins have been identified that allow shifting from one cell death pathway to another. Another layer of complexity is added by mechanisms such as the endosomal machinery, able to regulate the activation of some RCD pathways, preventing cell death. In addition, restricted axonal degeneration and synaptic pruning can occur as a result of RCD activation without loss of the cell body. RCD plays a complex role in neurodegenerative processes, varying across different disorders. It has been shown that RCD is differentially involved in Alzheimer's disease (AD) and amyotrophic lateral sclerosis (ALS), among the most common neurodegenerative diseases. In AD, neuronal loss is associated with the activation of not only necroptosis, but also pyroptosis. In ALS, on the other hand, motor neuron death is not linked to canonical necroptosis, whereas pyroptosis pathway activation is seen in white matter microglia. Despite these differences in the activation of RCD pathways in AD and ALS, the accumulation of protein aggregates immunoreactive for p62/SQSTM1 (sequestosome 1) is a common event in both diseases and many other neurodegenerative disorders. In this review, we describe the major RCD pathways with clear activation in AD and ALS, the main interactions between these pathways, as well as their differential and similar involvement in these disorders. Finally, we will discuss targeting RCD as an innovative therapeutic concept for neurodegenerative diseases, such as AD and ALS. Considering that the execution of RCD or "cellular suicide" represents the final stage in neurodegeneration, it seems crucial to prevent neuronal death in patients by targeting RCD. This would offer valuable time to address upstream events in the pathological cascade by keeping the neurons alive.

The role of death receptor in nervous system development and diseases

The Role of TNF Related Apoptosis-Inducing Ligand in Neurodegenerative Diseases.

Regulated cell death: discovery, features and implications for neurodegenerative diseases

The role of necroptosis in neurosurgical diseases.

The romantic history of signaling pathway discovery in cell death: an updated review

Gene Expression Regulation and the Signal Transduction of Programmed Cell Death

Protease Regulation: the Yin and Yang of Neural Development and Disease

Regulated cell death and its role in Alzheimer's disease and amyotrophic lateral sclerosis

Research Progress on the Role of Microglia Membrane Proteins or Receptors in Neuroinflammation and Degeneration

Role of Necroptosis in Central Nervous System Diseases

Different types of cell death and their shift in shaping disease

Different Ways to Die: Cell Death Pathways and Their Association With Spinal Cord Injury

Significance of Programmed Cell Death Pathways in Neurodegenerative Diseases

Friend or foe: role of pathological tau in neuronal death

Sweet Modification and Regulation of Death Receptor Signalling Pathway

Role of necroptosis in traumatic brain and spinal cord injuries

Non-coding RNAs in Ischemic Stroke: Roles in the Neuroinflammation and Cell Death

Cell death pathways: intricate connections and disease implications

Functional roles and networks of non-coding RNAs in the pathogenesis of neurodegenerative diseases

Necroptosis Signaling Pathways in Stroke: from Mechanisms to Therapies.

Dual Roles of NF-κB in Cell Survival and Implications of NF-κB Inhibitors in Neuroprotective Therapy